SCHEMBL27922909

SCHEMBL27922909

Clc1ccccc1C[Zn]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5111069 0.97 IDO1 (0.56)
Hydrochloric Acid SCHEMBL1014617 0.97 IDO1 (0.56)
Pivalate SCHEMBL9953468 0.79 NPC1 (0.46)
SCHEMBL6740216 0.79 TAAR1 (0.71)
SCHEMBL672407 0.79 IDO1 (0.62)
SCHEMBL29519238 0.79 IDO1 (0.62)
SCHEMBL126469 0.77
Bromide SCHEMBL11300760 0.76 PNMT (0.62)
Hydrochloric Acid SCHEMBL1043019 0.76 PNMT (0.62)
SCHEMBL2520376 0.74 IDO1 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117304191-A Fused pyrazine derivatives as A2A/A2B inhibitors 因赛特公司 2023-12-29 CN disclosed
CN-113166153-A Fused pyrazine derivatives as A2A/A2B inhibitors 因赛特公司 2021-07-23 CN disclosed
CN-108884070-B Pyridyl derivatives as bromodomain inhibitors 葛兰素史克知识产权第二有限公司 2021-07-02 CN disclosed
CN-106432213-A Heteroaryl derivatives as CFTR modulators 沃泰克斯药物股份有限公司 2017-02-22 CN disclosed
CN-103382201-B Heteroaryl derivative as CFTR regulator 沃泰克斯药物股份有限公司 2016-12-28 CN disclosed
CN-105008344-A Bruton's tyrosine kinase inhibitors PFIZER 2015-10-28 CN disclosed
CN-103951614-A Pyridyl derivatives as CFTR modulators VERTEX PHARMA 2014-07-30 CN disclosed
CN-102245573-B Heteroaryl derivatives as cftr modulators VERTEX PHARMA 2013-11-20 CN disclosed
CN-103382201-A Heteroaryl derivatives as cftr modulators VERTEX PHARMA 2013-11-06 CN disclosed